Ashmore-Harris, Candice http://orcid.org/0000-0001-9270-8599
Antonopoulou, Evangelia http://orcid.org/0000-0002-2801-6210
Finney, Simon M. http://orcid.org/0000-0003-4150-0784
Vieira, Melissa R. http://orcid.org/0009-0002-7956-0213
Hennessy, Matthew G. http://orcid.org/0000-0002-5928-6256
Muench, Andreas
Lu, Wei-Yu
Gadd, Victoria L. http://orcid.org/0000-0003-1819-8660
El Haj, Alicia J. http://orcid.org/0000-0003-3544-5678
Forbes, Stuart J.
Waters, Sarah L. http://orcid.org/0000-0001-5285-0523
Funding for this research was provided by:
RCUK | Medical Research Council (MR/T015489/1, MR/T015489/1, MR/T015489/1, MR/T015489/1, MR/T015489/1, MR/T015489/1, MR/T015489/1, MR/T015489/1)
Article History
Received: 5 July 2023
Accepted: 18 April 2024
First Online: 9 May 2024
Competing interests
: C.A.H., E.A., S.M.F., M.R.V., M.G.H., A.M., W.Y.L., V.L.G., A.E.H. and S.L.W. declare no conflicts of interest. S.J.F. is a founder and scientific advisor of Resolution Therapeutics Ltd and SensiBile (not related to this study) and on the scientific advisory board of Cytotheryx. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.